Real-time enrollment status for this autoimmune encephalitis (ae) clinical trial
Current Status
Recruiting
Checked: September 5, 2026 at 12:15 AM UTC
| NCT Number | NCT07583641 |
| Recruiting Status | Recruiting |
| Condition | Autoimmune Encephalitis (AE) |
| Phase | PHASE2 |
| Target Enrollment | 170 participants |
| Active Locations | 2 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | August 24, 2026 (1 week ago) |
As of September 5, 2026: Clinical trial NCT07583641 is currently recruiting participants. This phase2 study for autoimmune encephalitis (ae) is actively seeking new participants at 2 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07583641 is actively recruiting participants as of September 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07583641 was last updated 1 week ago (August 24, 2026). HelloStudys verifies this status automatically.